title: [Cardiotropic characteristics of mildronat].
abstract: The paper summarizes the literature data and the authors' own investigations on cardiotropic and clinical-pharmacological properties of Mildronat. The medication normalizes energy metabolism, optimizes the functions of the heart, and improves the health state of patients with angina pectoris and cardiac insufficiency.
authors: M I
authors: MI
authors: Zagorodnyĭ
authors: L I
authors: LI
authors: Kazak
authors: A S
authors: AS
authors: Svintsitskiĭ
authors: I S
authors: IS
authors: Chekman
mesh_terms: D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects*; D006801:Humans; D008763:Methylhydrazines / Q000627:therapeutic use*
chemical_list: D002317:Cardiovascular Agents; D008763:Methylhydrazines; C050147:3-(2,2,2-trimethylhydrazine)propionate